Trial intelligence / Profile preview

Xiaflex for Burn-Associated Contracture

NCT01237964Phase 2Unknown

Sponsor
Sheba Medical Center
Start
Mar 2011
Primary completion
Apr 2011
Modality
Therapeutic Enzymes
Countries
1
01

Overview

A Phase 2 trial of collagenase clostridium histolyticum in Burn contracture, sponsored by Sheba Medical Center. Status: unknown.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Burn contracture

Beyond the preview

Go deeper on NCT01237964.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01237964.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call